Review
Open access
Sep 2026
CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer.
The significance of the CRISPR/Cas9 genome editing system in the treatment of bladder cancer is emphasized and significant promise exists for improving the therapeutic potential of CRISPR-Cas9 technology and addressing complex cancer therapy difficulties because of the rapid development of nanotechnology-based delivery...
Swarupananda Mukherjee, D. Karati, Sinjini Sarkar et al.
· Nanomedicine · 0 citations